Transaction #27881 · Form 4 · 0001161697-26-000016
KORU Medical Systems, Inc. · Stock award · Common Stock
KORU Medical Systems, Inc. · Transacted December 31, 2025 · Filed January 5, 2026
What does this filing report?
An SEC Form 4 filing for KORU Medical Systems, Inc. records a stock award involving Common Stock on December 31, 2025. The reported quantity was 2,581. The filing date is January 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- KORU Medical Systems, Inc.
- Company CIK
- 0000704440
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 2,581
- Reported price
- 0 · See footnotes
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 5,832.916
- Ownership description
- By Horton Capital Partners Fund, LP
- SEC acceptance time
- Jan 5, 2026, 4:19 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Horton Capital Partners Fund, L.P. ↗
10% owner
CIK 0001567994
- Horton Capital Partners, LLC ↗
10% owner
CIK 0001575443
- Horton Capital Management, LLC ↗
10% owner
CIK 0001575444
- Manko Joseph M. Jr. ↗
Director · 10% owner
CIK 0001664091
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- See Exhibit 99.1 to this Form 4 for explanation of note (1).
- F2
- See Exhibit 99.1 to this Form 4 for explanation of note (2).
- F3
- See Exhibit 99.1 to this Form 4 for explanation of note (3).
Remarks
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.